Editorial Policy
Effective September 15, 2026
Buy This GLP covers the GLP-1 drugs sold online — semaglutide and tirzepatide, compounded and brand, by injection and by tablet. This is how we decide what goes on a page. It sits alongside our methodology (the scoring rubric), nature of reviews (what can and cannot move a verdict), and our disclosures (how we are paid).
1. Evidence does not transfer from the brand to the compound
We identify the formulation and dose studied when reporting trial results. Those results apply to the treatment tested. The FDA explains in its overview of compounded drugs that compounded preparations are outside its premarket review for safety, effectiveness and quality.
2. Sources for clinical and provider claims
We use trial publications, regulatory documents and official drug labels for clinical claims. For coverage and costs, we use sources such as insurer policies, public surveys and provider terms. Provider materials can document what a program offers. Clinical outcomes need evidence that applies to the product and dose in question.
When we quote provider marketing, we attribute the claim to the provider. Clinical claims need independent evidence specific to the treatment.
3. How we check and maintain citations
Our standard is to check a reference against the source of record and confirm that it supports the specific claim, including the population, product and period studied. During a factual review, we check whether the source still supports the wording and record the date and sources checked. We aim to repeat factual reviews every 60 days. A page’s revision date identifies when its copy changed. We use the corrections process to update claims when a source changes or a reader identifies an error.
4. Prices are read off the seller’s page, and dated
We use published provider prices and billing terms to identify what a quote includes. When we can verify a required fee or a prepaid term, we account for it in the comparison. The price freshness table shows when semaglutide injection prices were last checked. Confirm the current charge and supply period with the provider before paying.
When the provider publishes a starting price without specifying a dose or term, we describe that limitation. A comparison is more useful when both quotes cover the same medication, formulation and billing period.
5. Bylines and what we do not claim
Buy This GLP publishes the articles and reviews. The editorial coverage collections group that work by topic. This policy describes how the publisher selects and checks sources.
6. No clinician on staff, and we will not imply otherwise
Buy This GLP does not have a licensed clinician as a named medical reviewer. We do not claim individualized clinical review and we do not present any of this as care guidance. Our standard is primary-source verification, disclosed rather than dressed up — which is also why a medical disclaimer appears on our health content. Saying so costs us something in perceived authority; claiming a reviewer we do not have would cost you more.
7. AI assistance
We may use drafting tools, including AI, to help prepare copy. The publisher is responsible for checking claims against the sources and for correcting errors.
8. Corrections
We fix errors in public and date the change. If you find a misread figure, a stale price or a broken source link, see our corrections policy or write to pricing@buythisglp.com.